vs

Side-by-side financial comparison of NEKTAR THERAPEUTICS (NKTR) and Orion Properties Inc. (ONL). Click either name above to swap in a different company.

Orion Properties Inc. is the larger business by last-quarter revenue ($36.3M vs $21.8M, roughly 1.7× NEKTAR THERAPEUTICS). Orion Properties Inc. runs the higher net margin — -37.4% vs -165.4%, a 128.0% gap on every dollar of revenue. On growth, Orion Properties Inc. posted the faster year-over-year revenue change (-4.6% vs -25.3%). Over the past eight quarters, NEKTAR THERAPEUTICS's revenue compounded faster (0.4% CAGR vs -4.9%).

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

NKTR vs ONL — Head-to-Head

Bigger by revenue
ONL
ONL
1.7× larger
ONL
$36.3M
$21.8M
NKTR
Growing faster (revenue YoY)
ONL
ONL
+20.7% gap
ONL
-4.6%
-25.3%
NKTR
Higher net margin
ONL
ONL
128.0% more per $
ONL
-37.4%
-165.4%
NKTR
Faster 2-yr revenue CAGR
NKTR
NKTR
Annualised
NKTR
0.4%
-4.9%
ONL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NKTR
NKTR
ONL
ONL
Revenue
$21.8M
$36.3M
Net Profit
$-36.1M
$-13.6M
Gross Margin
Operating Margin
-126.9%
-9.3%
Net Margin
-165.4%
-37.4%
Revenue YoY
-25.3%
-4.6%
Net Profit YoY
-596.9%
-45.0%
EPS (diluted)
$-4.67
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NKTR
NKTR
ONL
ONL
Q1 26
$36.3M
Q4 25
$21.8M
$35.2M
Q3 25
$11.8M
$37.1M
Q2 25
$11.2M
$37.3M
Q1 25
$10.5M
$38.0M
Q4 24
$29.2M
$38.4M
Q3 24
$24.1M
$39.2M
Q2 24
$23.5M
$40.1M
Net Profit
NKTR
NKTR
ONL
ONL
Q1 26
$-13.6M
Q4 25
$-36.1M
$-35.8M
Q3 25
$-35.5M
$-69.0M
Q2 25
$-41.6M
$-25.1M
Q1 25
$-50.9M
$-9.4M
Q4 24
$7.3M
$-32.8M
Q3 24
$-37.1M
$-10.2M
Q2 24
$-52.4M
$-33.8M
Gross Margin
NKTR
NKTR
ONL
ONL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Operating Margin
NKTR
NKTR
ONL
ONL
Q1 26
-9.3%
Q4 25
-126.9%
-101.5%
Q3 25
-268.6%
-185.8%
Q2 25
-324.2%
-67.1%
Q1 25
-425.8%
-24.4%
Q4 24
49.2%
-85.4%
Q3 24
-142.4%
-25.9%
Q2 24
-211.9%
-84.1%
Net Margin
NKTR
NKTR
ONL
ONL
Q1 26
-37.4%
Q4 25
-165.4%
-101.7%
Q3 25
-301.3%
-186.0%
Q2 25
-372.2%
-67.3%
Q1 25
-486.4%
-24.6%
Q4 24
24.9%
-85.4%
Q3 24
-153.6%
-26.1%
Q2 24
-222.9%
-84.2%
EPS (diluted)
NKTR
NKTR
ONL
ONL
Q1 26
$-0.24
Q4 25
$-4.67
$-0.63
Q3 25
$-1.87
$-1.23
Q2 25
$-2.95
$-0.45
Q1 25
$-0.24
$-0.17
Q4 24
$-2.07
$-0.59
Q3 24
$-2.66
$-0.18
Q2 24
$-3.76
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NKTR
NKTR
ONL
ONL
Cash + ST InvestmentsLiquidity on hand
$15.1M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$89.8M
$608.5M
Total Assets
$280.4M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NKTR
NKTR
ONL
ONL
Q1 26
$10.3M
Q4 25
$15.1M
$22.4M
Q3 25
$41.0M
$32.6M
Q2 25
$43.0M
$17.4M
Q1 25
$38.9M
$9.4M
Q4 24
$44.3M
$15.6M
Q3 24
$30.1M
$16.6M
Q2 24
$27.9M
$24.2M
Total Debt
NKTR
NKTR
ONL
ONL
Q1 26
Q4 25
$465.0M
Q3 25
$483.0M
Q2 25
$483.0M
Q1 25
$505.0M
Q4 24
$492.0M
Q3 24
$485.0M
Q2 24
$462.0M
Stockholders' Equity
NKTR
NKTR
ONL
ONL
Q1 26
$608.5M
Q4 25
$89.8M
$623.2M
Q3 25
$85.1M
$658.8M
Q2 25
$-24.2M
$728.0M
Q1 25
$13.7M
$753.5M
Q4 24
$60.7M
$763.9M
Q3 24
$48.9M
$800.9M
Q2 24
$79.7M
$816.1M
Total Assets
NKTR
NKTR
ONL
ONL
Q1 26
$1.2B
Q4 25
$280.4M
$1.2B
Q3 25
$301.3M
$1.2B
Q2 25
$207.5M
$1.3B
Q1 25
$256.2M
$1.3B
Q4 24
$303.9M
$1.3B
Q3 24
$308.0M
$1.4B
Q2 24
$343.3M
$1.3B
Debt / Equity
NKTR
NKTR
ONL
ONL
Q1 26
Q4 25
0.75×
Q3 25
0.73×
Q2 25
0.66×
Q1 25
0.67×
Q4 24
0.64×
Q3 24
0.61×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NKTR
NKTR
ONL
ONL
Operating Cash FlowLast quarter
$-65.0M
Free Cash FlowOCF − Capex
$-65.0M
FCF MarginFCF / Revenue
-298.0%
Capex IntensityCapex / Revenue
0.1%
51.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NKTR
NKTR
ONL
ONL
Q1 26
Q4 25
$-65.0M
$23.6M
Q3 25
$-48.8M
$5.7M
Q2 25
$-45.7M
$11.6M
Q1 25
$-49.1M
$-2.2M
Q4 24
$-46.2M
$54.3M
Q3 24
$-43.9M
$13.8M
Q2 24
$-37.7M
$17.0M
Free Cash Flow
NKTR
NKTR
ONL
ONL
Q1 26
Q4 25
$-65.0M
Q3 25
$-48.9M
Q2 25
$-45.8M
Q1 25
$-49.1M
Q4 24
$-46.6M
Q3 24
$-44.6M
Q2 24
$-37.9M
FCF Margin
NKTR
NKTR
ONL
ONL
Q1 26
Q4 25
-298.0%
Q3 25
-414.5%
Q2 25
-409.6%
Q1 25
-469.0%
Q4 24
-159.9%
Q3 24
-184.9%
Q2 24
-161.3%
Capex Intensity
NKTR
NKTR
ONL
ONL
Q1 26
51.4%
Q4 25
0.1%
Q3 25
1.0%
Q2 25
0.3%
Q1 25
0.0%
Q4 24
1.6%
Q3 24
2.8%
Q2 24
0.8%
Cash Conversion
NKTR
NKTR
ONL
ONL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-6.36×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NKTR
NKTR

Segment breakdown not available.

ONL
ONL

Rental$36.1M100%
Fee income from unconsolidated joint venture$137.0K0%

Related Comparisons